News | December 03, 2025
Cleveland Diagnostics’ IsoPSA test for prostate cancer detection gains FDA approval
Now a test that offers new precision in prostate cancer detection
Now a test that offers new precision in prostate cancer detection
Soficitinib is a potent and selective TYK2 inhibitor under development for multiple T-cell mediated autoimmune disorders
The patent will lock in broad protection for the company’s lead therapy CardiolRx and its novel subcutaneous candidate CRD-38
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
The discussions come as part of the administration’s broader efforts to drive down drug prices and increase patient access to essential therapies
This partnership marks a significant step in strengthening Healthium’s position in the cardiac care segment
Cadila Pharmaceuticals has introduced Dlorfast-M-Tablets as a dual-action therapy that targets two key pathways of allergic response
Element5’s Agentic AI platform will be integrated with the HCHB EHR
Guidelines aim to establish state-regulated veterinary blood banks
The collaboration will combine Firstsource’s AI-first approach with Guidehealth’s expertise in value-based care innovation
Subscribe To Our Newsletter & Stay Updated
